Advisor OS’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$454K Sell
4,953
-334
-6% -$29.2K 0.03% 340
2026
Q1
$451K Buy
5,287
+851
+19% +$75.8K 0.03% 324
2025
Q4
$351K Buy
+4,436
New +$348K 0.03% 349
2025
Q3
Sell
-2,388
Closed -$217K 485
2025
Q2
$217K Buy
+2,388
New +$218K 0.02% 411
2025
Q1
Sell
-2,304
Closed -$209K 433
2024
Q4
$209K Buy
2,304
+65
+3% +$6.2K 0.02% 393
2024
Q3
$232K Sell
2,239
-109
-5% -$11.1K 0.02% 366
2024
Q2
$228K Buy
2,348
+101
+4% +$9.32K 0.02% 349
2024
Q1
$202K Buy
+2,247
New +$190K 0.02% 377
2020
Q3
Sell
-7,662
Closed -$561K 110
2020
Q2
$561K Buy
+7,662
New +$544K 0.33% 62

Other funds holding CL

Advisor OS's CL Position: Q2 2026 in Review

Advisor OS reduced its Colgate-Palmolive (CL) stake by 6.3% in Q2 2026, selling an estimated $29.2K and leaving 4,953 shares worth $454K. The position accounts for 0.03% of the portfolio, ranked #340.

Advisor OS first reported a position in CL in Q2 2020 and has held it in 9 quarters since. The position peaked at $561K in Q2 2020. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Advisor OS held 4,953 shares of Colgate-Palmolive worth $454K as of Q2 2026.
  • Advisor OS sold 334 Colgate-Palmolive shares in Q2 2026, an estimated $29.2K.
  • Colgate-Palmolive made up 0.03% of Advisor OS's portfolio in Q2 2026, its #340 holding.
  • Advisor OS first reported a position in Colgate-Palmolive in Q2 2020 and has held it in 9 quarters since.
  • Advisor OS's Colgate-Palmolive position peaked at $561K in Q2 2020.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Advisor OS's 13F filing for Q2 2026, filed 5 Aug 2026.